In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Mylan wins war; buys Merck Generics for $6.7bn

Executive Summary

Putting an end to a bidding war that started almost six months ago and involved multiple suitors, Mylan Laboratories has emerged the winner, agreeing to purchase Merck KGAA's Merck Generics unit for €4.9bn ($6.7bn) in an all-cash transaction.
Deal Industry
  • Pharmaceuticals
    • Generic Drugs
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register